Literature DB >> 11722070

Pneumoperitoneum for the management of pleural air space problems associated with major pulmonary resections.

T De Giacomo1, E A Rendina, F Venuta, F Francioni, M Moretti, F Pugliese, G F Coloni.   

Abstract

BACKGROUND: The use of pneumoperitoneum to treat prolonged air leaks or space problems, or both, after pulmonary resection has been recently resurrected and used successfully.
METHODS: During the last 3 years, 14 patients experienced short-term pleural space problems associated with prolonged air leaks after pulmonary resection for lung cancer. All patients, under sedation and local anesthesia, had a mean of 2,100 mL of air injected under the diaphragm, using a Veres needle after a mean time of 7 days (range, 5 to 10 days) from the operation. In 3 patients talc slurry was added to help control the air leak.
RESULTS: No patients experienced complications during the induction of the pneumoperitoneum. No patients complained of dyspnea, although blood gas analysis showed a slight increment of carbon dioxide partial pressure (p < 0.0004). Obliteration of the pleural space was observed in all cases after a mean time of 4 days (range, 1 to 7 days). Air leaks stopped in all patients after a mean time of 8 days (range, 4 to 12 days). The mean postoperative hospital stay after lung resection was 18 days (range, 14 to 22 days). No patients had significant complications or long-term sequelae. We found that patients who had undergone induction chemotherapy had longer air leak durations than observed in noninduction patients (p = 0.03).
CONCLUSIONS: Our experience supports the use of postoperative pneumoperitoneum whenever a space problem associated with prolonged air leaks is present. The procedure is effective, safe, and easy to perform.

Entities:  

Mesh:

Year:  2001        PMID: 11722070     DOI: 10.1016/s0003-4975(01)03050-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  The anticipation and management of air leaks and residual spaces post lung resection.

Authors:  Michael Rolf Mueller; Beatrice A Marzluf
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

2.  Experimental evaluation of a new system for laser tissue welding applied on damaged lungs.

Authors:  Marco Schiavon; Giuseppe Marulli; Andrea Zuin; Francesca Lunardi; Paolo Villoresi; Stefano Bonora; Fiorella Calabrese; Federico Rea
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-08

3.  Management of residual pleural space after lung resection: fully controllable paralysis of the diaphragm through continuous phrenic nerve block.

Authors:  Miriam Patella; Andrea Saporito; Francesco Mongelli; Ramon Pini; Rolf Inderbitzi; Stefano Cafarotti
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Management of residual spaces after lung resections and air leaks: Ultrasound and pneumoperitoneum.

Authors:  Gaetana Messina; Antonio Noro; Giovanni Natale; Mary Bove; Morena Fasano; Giovanni Vicidomini; Mario Santini; Alfonso Fiorelli
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15

5.  Early Induction of Bedside Pneumoperitoneum in the Management of Residual Pleural Space and Air Leaks After Pulmonary Resection.

Authors:  Alessandra Pecoraro; Giovanni Maria Garbarino; Valentina Peritore; Matteo Tiracorrendo; Claudio Andreetti; Mohsen Ibrahim; Erino Angelo Rendina; Paolo Mercantini
Journal:  World J Surg       Date:  2020-10-15       Impact factor: 3.352

6.  Clinical outcomes of polymeric sealant use in pulmonary resection: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Anna L McGuire; John Yee
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

7.  Use of a sealant to prevent prolonged air leaks after lung resection: a prospective randomized study.

Authors:  Cosimo Lequaglie; Gabriella Giudice; Rita Marasco; Aniello Della Morte; Massimiliano Gallo
Journal:  J Cardiothorac Surg       Date:  2012-10-08       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.